title: Correspondence to: Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Zapata
authors.forename: Joel
authors.initials: J
authors.lastname: Suárez
authors.forename: Teresa
authors.initials: T
authors.lastname: Minoves
authors.forename: Dulce
authors.initials: D
authors.lastname: Moncho
authors.forename: Anna
authors.initials: A
authors.lastname: Farriols
authors.forename: José
authors.initials: J
authors.lastname: Garcia-Arumi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha